ArticleUrolithiasis2025
Reno-protection by Didymocarpus pedicellata against oxalate-induced damage: mechanistic insights into mitigation of oxidative stress induced signaling pathways in renal cell line and rat model.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nesfatin‑1 Deficiency Exacerbates Calcium Oxalate Monohydrate-Induced Cellular Injury in Renal Epithelial Cells.ACS pharmacology & translational science · 2026Article
- Evaluation of potential ofFrontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress is a key driver of inflammatory injury which predisposes renal cells to nephrolithiatic damage. Recurrent stone formation is associated with cellular dysfunction, oxidative stress, inflammation and renal epithelial cell death. Didymocarpus pedicellata is an important medicinal herb in the ayurvedic system for the treatment of renal afflictions. The phytochemicals present in medicinal plants like D. pedicellata show potential in mitigating these series of cellular responses. Bioactivity guided fractionation, crystallization assays, phytochemical screening and GCMS analysis were performed to assess secondary metabolites present in D. pedicellata. The cytoprotective potential of the extract was evaluated by assessing cell viability, reactive oxygen species (ROS) generation, analyzing cell death, and gene expression changes to determine the extent of damage caused by oxalate exposure. The crystal-cell interface, adhesion dynamics, and morphological alterations were characterized using histological analysis via hematoxylin and eosin staining and ultrastructural examination by scanning electron microscopy. Hyperoxaluric rat model was generated by treating the rats with ethylene glycol and ammonium chloride to induce nephrocalcinosis and the effects of treatment with D. pedicellata were evaluated using renal physiology biomarkers, microscopic analysis of urine and histological studies for crystal deposition and kidney tissue injury. Gene expression analysis of p38 Mitogen-activated protein kinase and Osteopontin was done to assess the expression levels due to hyperoxaluria and treatment with D. pedicellata extract. D. pedicellata extract showed cytoprotective potential through in vitro and in vivo studies. Antilithiatic efficacy was evaluated through crystallization assays which led to metabolic profiling through GCMS analysis exhibiting a wide range of secondary metabolites with antioxidant and anti-inflammatory properties. Our study demonstrated that oxalate injured NRK52-E renal epithelial cells when cotreated with ethanolic extract of D. pedicellata led to an overall increase in cell viability, reduced production of intracellular reactive oxygen species (ROS) which lowered oxidative damage in the cells and decreased apoptosis. Staining the tissues with H&E and SEM imaging revealed modulation of crystal structure and enhanced adhesion to renal epithelial cells. Further evaluation of calcium oxalate deposition in rat model revealed that D. pedicellata alleviated crystal deposition and kidney tissue injury as evaluated by urine analysis and histological studies and decreased expression of inflammatory markers p38MAPK and Osteopontin. This study demonstrates that D. pedicellata exerts cytoprotective effect against calcium oxalate induced nephrocalcinosis by reducing the production of reactive species, oxidative stress, lowering inflammation and apoptosis finally reducing renal injury.
Indexed as
Identifiers
40586959What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.